Tech Company Financing Transactions

Color Health Funding Round

On 1/6/2021, Color Health secured $167 million in Series D funding from General Catalyst Partners, T. Rowe Price and private investors.

Transaction Overview

Company Name
Announced On
1/6/2021
Transaction Type
Venture Equity
Amount
$167,000,000
Round
Series D
Investors
Proceeds Purpose
The company will use the funding to expand its work building public health technology and infrastructure for governments, employers, and other institutions that serve large populations.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
831 Mitten Rd.
Burlingame, CA 94010
USA
Email Address
Overview
Color's mission is to help people lead the healthiest lives that science and medicine can offer. We launched in April 2015 with a simple, affordable genetic test to help people understand their risk for hereditary cancer. In 2017, we added coverage for hereditary heart conditions.
Profile
Color Health LinkedIn Company Profile
Social Media
Color Health Company Twitter Account
Company News
Color Health News
Facebook
Color Health on Facebook
YouTube
Color Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Othman Laraki
  Othman Laraki LinkedIn Profile  Othman Laraki Twitter Account  Othman Laraki News  Othman Laraki on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/5/2021: AI Clearing venture capital transaction
Next: 1/6/2021: Botanical Solutions venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary